| Net Income Attributable to Kadant |
24.34M |
| Net income attributable to noncontrolling interest |
318K |
| Loss from discontinued operation |
-3K |
| Income from Continuing Operations |
24.66M |
| Depreciation and amortization |
10.93M |
| Stock-based compensation expense |
3.87M |
| Provision for losses on accounts receivable |
420K |
| Gain on the sale of property, plant, and equipment |
-384K |
| Other items, net |
256K |
| Accounts receivable |
3.73M |
| Unbilled contract costs and fees |
1.71M |
| Inventories |
2.05M |
| Other current assets |
| Accounts payable |
-5.6M |
| Other current liabilities |
| Contributions to pension plan |
| Net cash provided by continuing operations |
34.74M |
| Net cash provided by discontinued operation |
-2K |
| Net cash provided by operating activities |
34.74M |
| Acquisitions, net of cash acquired (Note 3) |
| Purchases of property, plant, and equipment |
-3.58M |
| Dividend paid to minority shareholder |
| Proceeds from sale of property, plant, and equipment |
409K |
| Other, net |
| Net cash used in continuing operations for investing activities |
| Repayments of short- and long-term obligations |
-15.43M |
| Change in restricted cash |
-793K |
| Proceeds from issuance of Company common stock |
1.78M |
| Other, net |
-27K |
| Net cash used in continuing operations for financing activities |
| Exchange Rate Effect on Cash and Cash Equivalents |
| Increase (Decrease) in Cash and Cash Equivalents |
| Cash and Cash Equivalents at Beginning of Period |
65.53M |
| Cash and Cash Equivalents at End of Period |
63.24M |
| Fair value of assets acquired |
| Cash paid for acquired business |
| Liabilities assumed of acquired business |
| Issuance of Company common stock |
